Skip to content
2000
Volume 7, Issue 6
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Typically, malignant melanoma has wild-type p53, and yet this cancer proliferates. S100B, which binds p53 and is up-regulated in melanoma, down-regulates wild-type p53 tumor suppressor function. Inhibitors of the S100B-p53 interaction were identified using computer aided drug design (CADD) combined with NMR methodologies and represent potentially new chemotherapeutics for melanoma.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955707780859422
2007-06-01
2025-06-27
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955707780859422
Loading

  • Article Type:
    Research Article
Keyword(s): calcium; cancer; drug design; inhibitors; p53; S100B
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test